Matt Bull is an experienced leader in pharmaceuticals and diagnostics, specializing in strategy development and P&L management. They served as a Medical Sales Representative at Aventis from 1999 to 2000 before progressing to various key roles at Novartis, including Franchise Head for Oncology and Business Franchise Head for Rare Diseases. They held leadership positions at Amgen from 2019 to 2022, directing the UK oncology business, and are currently the Head of International Commercial Excellence at Exact Sciences. Matt's extensive background in oncology, haematology, and international commercial operations highlights their strategic impact in the industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices